Specialized expertise and customized solutions across 14 therapeutic centers of excellence, including oncology, GI/NASH, pediatrics, neurology and rare diseases.
Unlock the full potential of your obesity program with IQVIA’s integrated solutions and unmatched therapeutic expertise. Our expert teams have a proven track record of driving speed and precision across the entire drug development lifecycle.
We employ everything your program needs, from cutting-edge bioanalysis methodologies through to successful patient recruitment strategies, all while consistently leveraging cross-therapeutic insights to address obesity and related comorbidities.
Be sure to attend our poster presentation, “LC-MS as an Essential Tool for GLP-1/GIP Drug DMPK Studies” from our biotransformation expert, Tom Fleischmann, Ph.D. on the following dates and times:
11/4 - 7:30 - 8:30pm EST
11/5 - 2:30 - 3:30pm EST
11/6 - 2:30 - 3:30pm EST
IQVIA services are designed to keep patients at the center of innovation, and we know that obesity trials demand more than execution. Let’s connect at ObesityWeek® 2025 and build the future of treatment together, faster.
Stop by one our booths to say hello!
IQVIA booth 821
IQVIA Laboratories booth 824
Our dedicated experts from IQVIA and IQVIA Laboratories will be there to discuss how to support your obesity study from trial design and delivery to commercial optimization.
We hope to see you in Atlanta! For more information about ObesityWeek® 2025, please visit: ObesityWeek - Innovative Science to Transformational Care
Specialized expertise and customized solutions across 14 therapeutic centers of excellence, including oncology, GI/NASH, pediatrics, neurology and rare diseases.
Accelerate your obesity trial timelines with solutions designed for rapid execution by leveraging our team of seasoned experts and advanced patient recruitment solutions.